These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 3724301

  • 1. Anti-shock actions of the pyrimido-pyrimidine derivative, RA-642.
    Hock CE, Lefer DJ, Lefer AM.
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):265-9. PubMed ID: 3724301
    [Abstract] [Full Text] [Related]

  • 2. Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock.
    Bitterman H, Smith BA, Lefer AM.
    Arzneimittelforschung; 1988 Oct; 38(10):1389-93. PubMed ID: 3196378
    [Abstract] [Full Text] [Related]

  • 3. [Effects of 2,2'-[(4,8-bis(diethylamino)-pyrimido[5,4-d]pyrimidine-2,6-diyl) di-(2-methoxyethyl)imino]diethanol (RA 642) on experimental scald shock].
    Yin M, Liao XL, Tan SJ.
    Zhongguo Yao Li Xue Bao; 1987 Nov; 8(6):533-6. PubMed ID: 3451667
    [No Abstract] [Full Text] [Related]

  • 4. Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock.
    Hock CE, Lefer AM.
    Circ Shock; 1984 Nov; 14(3):159-68. PubMed ID: 6542462
    [Abstract] [Full Text] [Related]

  • 5. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock.
    Hock CE, Lefer AM.
    Circ Shock; 1985 Nov; 17(4):263-72. PubMed ID: 3841503
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of two leukotriene antagonists in rat traumatic shock.
    Levitt MA, Lefer AM.
    Methods Find Exp Clin Pharmacol; 1987 May; 9(5):269-73. PubMed ID: 3613754
    [Abstract] [Full Text] [Related]

  • 10. Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
    Aoki N, Johnson G, Siegfried MR, Lefer AM.
    Eicosanoids; 1989 May; 2(3):169-74. PubMed ID: 2534278
    [Abstract] [Full Text] [Related]

  • 11. Protective actions of aprotinin in acute traumatic shock.
    Araki H, Lefer AM.
    Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):316-23. PubMed ID: 316692
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shock.
    Stahl GL, Bitterman H, Lefer AM.
    Thromb Res; 1989 Feb 01; 53(3):327-38. PubMed ID: 2718150
    [Abstract] [Full Text] [Related]

  • 19. Anti-shock actions of a new converting enzyme inhibitor, enalaprilic acid, in hemorrhagic shock in cats.
    Freeman JG, Hock CE, Edmonds JS, Lefer AM.
    J Pharmacol Exp Ther; 1984 Dec 01; 231(3):610-5. PubMed ID: 6094795
    [Abstract] [Full Text] [Related]

  • 20. Oxygen therapy in hemorrhagic shock.
    Bitterman H, Reissman P, Bitterman N, Melamed Y, Cohen L.
    Circ Shock; 1991 Mar 01; 33(3):183-91. PubMed ID: 2044210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.